Novartis (NYSE:NVS) division Sandoz said today that it launched its Symjepi epinephrine pre-filled syringe in the U.S.
The company’s product is designed as an alternative to epinephrine auto-injectors to treat emergency allergic reactions.
Get the full story at our sister site, Drug Delivery Business News.
The post Sandoz launches PFS alternative to epinephrine auto-injector appeared first on MassDevice.